Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term - Top-Institutions - MDSpire

Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term

  • By

  • Sergio Cortelazzo

  • Michael Mian

  • Andrea Evangelista

  • Liliana Devizzi

  • Paolo Corradini

  • Michele Magni

  • Marco Ladetto

  • Simone Ferrero

  • Andrea Rossi

  • Anna Maria Barbui

  • Caterina Patti

  • Alessandro Costa

  • Umberto Vitolo

  • Annalisa Chiappella

  • Fabio Benedetti

  • Andrés J. M. Ferreri

  • Paolo Nicoli

  • Luigi Rigacci

  • Claudia Castellino

  • Alessandro M. Gianni

  • Alessandro Rambaldi

  • Corrado Tarella

  • July 7, 2021

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation

  • #4

    European Institute of Oncology
    European Institute of Oncology

    Milan, Lombardy

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation

  • #5

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation

Original Source(s)

Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term

  • by Sergio Cortelazzo, Michael Mian, Andrea Evangelista, Liliana Devizzi, Paolo Corradini, Michele Magni, Marco Ladetto, Simone Ferrero, Andrea Rossi, Anna Maria Barbui, Caterina Patti, Alessandro Costa, Umberto Vitolo, Annalisa Chiappella, Fabio Benedetti, Andrés J. M. Ferreri, Paolo Nicoli, Luigi Rigacci, Claudia Castellino, Alessandro M. Gianni, Alessandro Rambaldi, Corrado Tarella

  • July 7, 2021

Related Content

The First NCI-Designated Comprehensive Cancer Center Using 3D Genomics Testing to Diagnose Lymphoma and Sarcoma—a True Game Changer

Diagnosing lymphoma and sarcoma can be extraordinarily complex, with more than 70 recognized subtypes of lymphoma and more than 100 distinct types of sarcoma. Many subtypes share similar features yet behave in dramatically different ways in standard testing, leaving oncologists with diagnostic quandaries and delays to treatment.

  • by

  • February 24, 2026

  • 4 min
Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

Case Report: Extranodal marginal zone B-cell lymphoma in the lateral ventricle: literature review